While nausea, vomiting, and diarrhea are the most commonly reported gastrointestinal adverse effects with GLP-1-based therapies (occurring in 15-40% of patients depending on the agent and dose), FDA prescribing information for several of these medications does list dyspepsia (indigestion) and, in some cases, gastroesophageal reflux disease (GERD) as reported adverse reactions
By optimising how your body uses fat for energy, it can help improve endurance and reduce the reliance on glycogen stores
Effects of different dietary interventions in multiple sclerosis: a systematic review of evidence from 2018 to 2022
For patients who want to understand BPC-157 in more depth before considering the combination, our standalone guide to BPC-157 explains how this targeted repair peptide works at the injury site and when Perfect B prescribes it as a standalone versus in combination with TB-500
The blend is supplied strictly for laboratory research use only and is not intended for human consumption, clinical, cosmetic, diagnostic or veterinary application